INTERNATIONAL UROLOGY AND NEPHROLOGY, vol.50, no.2, pp.247-255, 2018 (SCI-Expanded)
Renal cell carcinoma (RCC) accounts for approximately 80% of the primary renal cancers, and current treatment strategies are not sufficient to provide a certain solution. Since there are not many treatment options, interest in discovery of alternative drugs has increased.